Misregulation of the CXCR4‐CXCL12 signaling axis is associated with numerous pathological conditions, including various cancers, chronic inflammatory diseases, cardiovascular diseases, and immunodeficiencies (Britton et al., 2021). Here, CXCL12 is linked to cancer.